Table 1.

Baseline characteristics of study population (n = 55)

Clinical and epidemiological variables	Results
Age at baseline (years) (M ± SE)	44.7 ± 1.3
Sex (male/female)	14/41
Disease duration (months) (M ± SE)	155.1 ± 25.5
EDSS score at baseline (M ± SE)	2.4 ± 0.3
Relapses in the 2 years before treatment (M ± SE)	0.8 ± 0.1
Previous treatments	13 N; 35 FL; 7 SL
Number of previous treatments	13(N); 27(1); 7(2);8(≥3)
Washout period (months) (M ± SE)	8.5 ± 2.3

FL: prior treatment with first line drugs; M ± SE, Mean±Standard error; N, no previous disease‐modifying treatment; SL, prior treatment with second‐line drugs; (1): Prior treatment with one disease‐modifying drug; (2): prior treatment with two disease‐modifying drugs; (≥3): prior treatment with three or more drugs.